SFT2 Antibody

What is SFT2D2 and what cellular functions does it mediate?

SFT2D2, also known as Vesicle transport protein SFT2B, is a membrane protein involved in intracellular trafficking and vesicle fusion processes. This protein ensures accurate sorting and delivery of proteins and lipids which are essential for maintaining cellular homeostasis. Its coordination with proteins such as Syntaxin 5 ensures seamless progression of synthesized proteins to their destinations . Research has established that SFT2D2 may be specifically involved in the fusion of retrograde transport vesicles derived from endocytic compartments with the Golgi complex . Recent studies have further characterized SFT2D2 as a downstream effector of the Arl1-Imh1 axis that facilitates SNARE transport during ER stress conditions .

What types of SFT2D2 antibodies are currently available for research?

Current research tools include primarily rabbit polyclonal antibodies against SFT2D2. These antibodies are suitable for multiple applications including Western blot (WB), immunocytochemistry/immunofluorescence (ICC/IF), and ELISA techniques . Most commercially available antibodies have validated reactivity with human and mouse samples, with some also confirmed for rat specimens . The immunogens used to generate these antibodies typically correspond to regions within the human SFT2D2 protein, such as amino acids 1-50 or synthesized peptides derived from internal regions of human SFT2B .

How can I validate the specificity of my SFT2D2 antibody?

To validate SFT2D2 antibody specificity, a multi-method approach is recommended:

• Western blot validation: Compare band patterns across multiple tissue lysates. Published data shows expected bands at approximately 17 kDa in mouse liver, kidney, and thymus tissue lysates .

• Cellular localization: Confirm the antibody detects SFT2D2 in its expected subcellular localization (Golgi apparatus) using ICC/IF. Previous studies show SFT2 colocalizes with Sec7 (late-Golgi marker), Arl1, and Imh1 .

• Knockout/knockdown controls: Where possible, use SFT2D2 knockout or knockdown samples as negative controls.

• Cross-reactivity assessment: Test the antibody against related proteins, especially other SFT2 domain-containing proteins, to ensure specificity.

What are the optimal protocols for using SFT2D2 antibodies in Western blot analyses?

Based on published research methodologies, the following protocol is recommended for Western blot analysis using SFT2D2 antibodies:

For optimal results, include positive control lysates such as mouse liver tissue, which has shown reliable SFT2D2 detection in previous studies . When analyzing tissue-specific expression patterns, note that protein levels may vary significantly between tissue types.

How should SFT2D2 antibodies be used for immunofluorescence studies?

For successful immunofluorescence detection of SFT2D2:

• Fixation: 4% paraformaldehyde for 15 minutes at room temperature.

• Permeabilization: 0.25% Triton X-100 in PBS for 10 minutes.

• Blocking: 1-5% BSA in PBS with 0.1% Tween-20 for 30 minutes.

• Primary antibody: Dilute SFT2D2 antibody at 1:100 for cellular visualization .

• Secondary antibody: Alexa-Fluor 488® conjugated anti-rabbit IgG at 1:500.

• Co-staining markers: For subcellular localization, consider co-staining with Golgi markers such as Sec7 or GM130.

When analyzing SFT2D2 localization under stress conditions, researchers should note that SFT2 colocalizes with amplified puncta formed by Arl1–Imh1 proteins under tunicamycin-induced stress .

How does SFT2D2 function in the SNARE-mediated vesicle transport pathway?

Research has revealed that SFT2D2 functions as a critical component in the SNARE-mediated vesicle transport pathway. Specifically:

• SFT2 acts as a downstream regulator of the Arl1-Imh1 axis to facilitate Tlg1/Snc1 SNARE transport during tunicamycin (TM)-induced ER stress .

• The targeting of SFT2 to the late-Golgi depends on Imh1-regulated Tlg2 retrograde transport under ER stress conditions .

• The N-terminal region (first 40 amino acids) of SFT2 is essential for:

  • Mediating SNARE recycling

  • Enhancing the interaction between Tlg1 and Snc1

  • Proper function under ER stress conditions

• SFT2 is required for GARP-dependent endosome-to-Golgi transport, particularly in the absence of the Rab protein Ypt6 .

These findings highlight SFT2D2 as an important connector in the sequential docking of Tlg2-Sft2-Tlg1 on the late-Golgi, which is crucial for proper protein trafficking under stress conditions.

What experimental approaches can be used to study SFT2D2's role in ER stress response?

To investigate SFT2D2's role in ER stress response, researchers can employ the following experimental approaches:

• Tunicamycin treatment: Induce ER stress using tunicamycin (TM) treatment (1-5 μg/ml for 2-4 hours) to observe SFT2D2 dynamics during stress conditions .

• Colocalization studies:

  • Track SFT2D2 colocalization with late-Golgi markers (Sec7) and SNARE proteins (Tlg1, Snc1)

  • Compare localization patterns between normal and ER stress conditions

  • Utilize fluorescently tagged proteins to visualize trafficking in real-time

• Protein interaction studies:

  • Co-immunoprecipitation to detect SFT2D2 interactions with SNAREs

  • Yeast two-hybrid assays to map interaction domains

  • Proximity ligation assays for in situ interaction confirmation

• N-terminal truncation experiments: Generate SFT2D2 constructs with N-terminal deletions to assess functional importance of this region in SNARE recycling .

• Combined treatment approaches: After TM treatment, use latrunculin B (Lat-B) to inhibit endocytosis by preventing actin polymerization, which helps distinguish defects in anterograde versus retrograde transport .

How do functional defects in SFT2D2 affect cellular homeostasis?

Disruption of SFT2D2 function has significant consequences for cellular homeostasis:

• SNARE trafficking disruption: Deletion of SFT2 (sft2Δ) results in mislocalization of Tlg1/Snc1 SNAREs, phenocopying the pattern observed in imh1Δ cells .

• Golgi accumulation: In sft2Δ cells under ER stress, GFP-Snc1 accumulates in the late-Golgi (colocalizing with Sec7), indicating defective anterograde transport to the plasma membrane .

• Transport pathway impairment: SFT2D2 deficiency compromises the GARP-dependent endosome-to-Golgi transport pathway, particularly when the Rab protein Ypt6 is absent .

• Stress response defects: Without functional SFT2D2, cells cannot properly adapt their membrane trafficking pathways in response to ER stress, potentially leading to compromised cellular viability under stress conditions.

• Potential disease implications: While not directly demonstrated in the provided research, the disruption of protein trafficking pathways is implicated in various neurodegenerative disorders and may represent an area for future investigation regarding SFT2D2 dysfunction.

What are common issues encountered when using SFT2D2 antibodies and how can they be resolved?

How can I optimize detection of endogenous versus overexpressed SFT2D2?

Detecting endogenous versus overexpressed SFT2D2 requires different optimization strategies:

For endogenous SFT2D2 detection:

• Use tissues/cells known to express SFT2D2 (liver, kidney, thymus have shown good detection)

• Employ more sensitive detection methods (ECL Prime or similar)

• Increase antibody concentration (1:500 dilution) and extend incubation time

• Consider using signal enhancement systems for IF applications

• Concentrate protein from larger sample volumes when necessary

For overexpressed SFT2D2 detection:

• Reduce antibody dilution (1:1000-1:3000) to prevent oversaturation

• Decrease exposure time in Western blots to avoid signal saturation

• Use lower magnification for initial IF imaging to capture expression patterns

• Consider using epitope tags (His, FLAG, etc.) as alternative detection strategy

• Include appropriate empty vector controls to assess specificity

Comparative considerations:

• When comparing endogenous and overexpressed protein, maintain identical detection parameters

• Include loading controls appropriate for the subcellular fraction being examined

• Consider downstream analysis tools that can quantify differences in expression levels

What recent advances have been made in understanding SFT2D2's role in disease mechanisms?

While the search results don't directly address SFT2D2's role in disease mechanisms, emerging research indicates potential areas for investigation:

• Membrane trafficking disorders: Given SFT2D2's role in vesicle transport, dysfunction could contribute to conditions characterized by intracellular trafficking defects.

• ER stress-related pathologies: The demonstrated importance of SFT2D2 in ER stress response suggests potential involvement in diseases associated with chronic ER stress, including neurodegenerative disorders and certain metabolic conditions.

• Golgi integrity maintenance: As a Golgi-resident protein involved in retrograde transport , SFT2D2 dysfunction might impact Golgi morphology and function, which is implicated in various congenital disorders of glycosylation.

• SNARE recycling pathways: Disruption of the SFT2D2-dependent SNARE recycling pathway could impact multiple cellular processes dependent on membrane fusion events.

Future research should investigate potential correlations between SFT2D2 expression/function alterations and disease phenotypes, particularly those involving secretory pathway dysfunction.

What methodological advances would enhance SFT2D2 functional studies?

To advance functional studies of SFT2D2, researchers should consider these emerging methodological approaches:

• CRISPR-Cas9 genome editing: Generation of precise SFT2D2 knockout or knock-in cell lines for detailed functional analysis, including domain-specific mutations targeting the critical N-terminal region .

• Advanced imaging techniques:

  • Super-resolution microscopy for precise subcellular localization

  • Live-cell imaging with photoactivatable fluorescent proteins to track SFT2D2 dynamics

  • Correlative light and electron microscopy (CLEM) to visualize SFT2D2 in context of membrane structures

• Proximity labeling approaches: BioID or APEX2 fusion proteins to identify the complete SFT2D2 interactome under normal and stress conditions.

• In vitro reconstitution assays: Purified components to reconstitute SFT2D2-mediated membrane fusion events and directly measure its impact on SNARE complex formation.

• Tissue-specific conditional knockout models: To evaluate SFT2D2 function in specialized cell types and avoid potential developmental complications of constitutive knockout.

These approaches would provide deeper mechanistic insight into how SFT2D2 coordinates with the Arl1-Imh1 axis and SNARE proteins to maintain proper vesicular trafficking.